What is HC Wainwright’s Estimate for APLS Q1 Earnings?
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – HC Wainwright lifted their Q1 2025 earnings estimates for Apellis Pharmaceuticals in a research note issued on Monday, March 3rd. HC Wainwright analyst D. Tsao now expects that the company will earn ($0.47) per share for the quarter, up from their previous forecast of ($0.55). HC Wainwright […]
